Despite advances in cardiovascular care, managing cardiogenic shock caused by structural heart disease is challenging. Patients with cardiogenic shock are critically ill upon presentation and require early disease recognition and rapid escalation of care. Temporary mechanical circulatory support provides a higher level of care than current medical therapies such as vasopressors and inotropes. This review article focuses on the role of hemodynamic monitoring, mechanical circulatory support, and device selection in patients who present with cardiogenic shock due to structural heart disease. Early initiation of appropriate mechanical circulatory support may reduce morbidity and mortality.
Keywords: Aortic regurgitation; Aortic stenosis; Cardiogenic shock; Mechanical circulatory support; Mitral regurgitation; Mitral stenosis.
Copyright © 2020 Elsevier Inc. All rights reserved.